Insider Transaction Report for Pardeep Nijhawan

This filing details a transaction by Pardeep Nijhawan, CEO of Edesa Biotech, Inc. On October 5, 2026, Mr. Nijhawan acquired 6,893 common shares through a grant of restricted share units that vested immediately. These shares were acquired at a price of $0.00, as indicated by footnote F1, which clarifies that this relates to a grant of restricted share units under the company's 2019 Equity Incentive Compensation Plan. Following this transaction, Mr. Nijhawan has a total of 905,993 shares. The filing also discloses holdings in various entities: 402,702 shares held by Pardeep Medicine Professional Corporation, 32,609 shares by The New Nijhawan Family Trust 2015, 32,013 shares by The Digestive Health Clinic Inc., and 53,104 shares by 1968160 Ontario Inc. Mr. Nijhawan disclaims beneficial ownership of the shares held by these entities, except to the extent of his pecuniary interest.